Noven to Present at R.W. Baird Growth Stock Conference

Related Content

MIAMI --
Noven Pharmaceuticals, Inc. (NASDAQ:NOVN) today announced that Jeffrey F. Eisenberg, Noven's Executive Vice President, is scheduled to present an update on Noven's business and prospects at the Robert W. Baird 2008 Growth Stock Conference in Chicago, IL on Tuesday, May 13 at 1:55 p.m. CT (2:55 p.m. ET). The presentation will be webcast live at www.noven.com, and a rebroadcast will be available thereafter at the same site.

About Noven

Noven Pharmaceuticals, Inc. is a specialty pharmaceutical company engaged in the research, development, manufacture, marketing and sale of prescription pharmaceutical products. Noven's business and operations are focused in three principal areas - transdermal drug delivery, the Novogyne joint venture, and its Noven Therapeutics specialty pharmaceutical unit.

Noven Pharmaceuticals, Inc., Miami Alina Bowman, Investor Relations Coordinator 305-253-1916

 

Join the discussion

The Miami Herald is pleased to provide this opportunity to share information, experiences and observations about what's in the news. Some of the comments may be reprinted elsewhere in the site or in the newspaper. We encourage lively, open debate on the issues of the day, and ask that you refrain from personal comments and remarks that are off point. In order to post comments, you must be a registered user of MiamiHerald.com. Your username will show along with the comments you post. Not a registered user? It's Free! Register here. Thank you for taking the time to offer your thoughts.

Quick Job Search

Enter Keyword(s):
Enter City:
Select a State:
Select a Category:
Search by Category
Advanced Job Search

BUSINESS NEWS VIDEO